Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Novartis Trims Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback
Tickers NEWS NVS
Tags Buybacks Biotech Benzinga
From Benzinga
Earnings Scheduled For July 17, 2025
Tickers ABT BSVN CFG CNS
Tags WBS MCB MAN
From Benzinga
Earnings Outlook For Novartis
Tickers NVS
Tags BZI/EP Market News Earnings
From Benzinga
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
Tickers AZN FTXH IHE KURE
Tags QQQ IHE KURE
From Benzinga
3 Medical Stocks To Watch As Q2 Earnings Approach: ABT, JNJ, NVS
Tickers ABT JNJ NVS
Tags ABT JNJ NVS
From TalkMarkets
Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study
Tickers ALPMF ALPMY NEWS NVS
Tags NVS Market News Health Care
From Benzinga
How Do Investors Really Feel About Novartis?
Tickers NVS
Tags Benzinga NVS Short Sellers
From Benzinga
Novartis Gets Swiss Approval For First Malaria Drug For Babies
Tickers NEWS NVS
Tags Briefs General Top Stories
From Benzinga
Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is...'
Tickers AMD GOOG GOOGL LLY
Tags Market News RXRX NVS
From Benzinga
Better Dividend ETF to Buy for Passive Income: SCHD or GCOW
Tickers AMGN BP BTI COP
Tags KO BP MO
From Motley Fool
Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial
Tickers ABBV NEWS NVS
Tags Top Stories General Briefs
From Benzinga
Is Pfizer Stock a Yield Trap?
Tickers BBIO BMY NVS PFE
Tags PFE Recent Press Releases BBIO
From Motley Fool
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
Tickers ACLX AUTL BMY CABA
Tags GILD Large Cap Stories That Matter
From Benzinga
Could This Be the Best High-Dividend ETF to Buy Right Now?
Tickers NSRGY NVS RY TM
Tags VYM TM Recent Press Releases
From Motley Fool
Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis' Zolgensma
Tickers BIIB IONS NEWS NVS
Tags Health Care Large Cap News
From Benzinga
Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside
Tickers NEWS NVS RHHBY SEPN
Tags Analyst Color NVS Price Target
From Benzinga
Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Company
Tickers LLY NEWS NVO NVS
Tags NVO Briefs General
From Benzinga
Novartis' Fabhalta Delivers Hemoglobin Gains, Reduces Fatigue In Patients With Rare Blood Disorder
Tickers AZN NEWS NVS
Tags Biotech AZN Benzinga
From Benzinga
2 Dividend Growth Stocks to Buy and Hold Forever
Tickers AMGN NVS
Tags Market News NVS AMGN
From Motley Fool
Is Novartis Gaining or Losing Market Support?
Tickers NVS
Tags Market News Short Sellers NVS
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ABBV AMGN COR GILD
Tags REGN VEEV AMGN
From Benzinga
10 International Dividend Aristocrats With Exceptional Dividend Growth Histories
Tickers CDUAF CNI FTS LRLCF
Tags SNY NVO Stocks / Equities
From TalkMarkets
The Smartest Vanguard ETF to Buy With $500 Right Now
Tickers AEP ASML CEG DUK
Tags VPU NSRGY CEG
From Motley Fool
Lazard Transforms Mutual Fund Into IEQ ETF Amid Rising Demand For International Stocks
Tickers BABA IBDRY IEQ JPY
Tags IEQ TSM New ETFs
From Benzinga
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Tickers BDX BMY JNJ LLY
Tags TMO Movers why it's moving
From Benzinga
Protagonist/Johnson & Johnson Partnered Drug Shows Significant Skin Clearance In Pivotal Psoriasis Study
Tickers JNJ NEWS NVS PTGX
Tags Benzinga JNJ Biotech
From Benzinga
FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
Tickers BDX BMY JNJ LLY
Tags Biotech FDA JNJ
From Benzinga
BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion
Tickers BNTX NEWS NVS PFE
Tags General Top Stories Briefs
From Benzinga
Humana Does Not Alter 2025 Outlook Despite Sales Miss And Medicare Membership Decline
Tickers HUM NEWS NVS
Tags Stories That Matter Guidance Large Cap
From Benzinga
Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million
Tickers NEWS NVS RGLS
Tags Trading Ideas Large Cap Benzinga
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.